Ischemic Stroke News and Research

RSS

About 1 in 5 stroke survivors found to have irregular heart rhythms

Irregular heart rhythms were detected in about 1 in 5 people who survived an ischemic stroke due to atherosclerosis (buildup of fatty substances in the arteries) after being continuously monitored for three years with an insertable cardiac device, according to preliminary late-breaking science presented at the American Stroke Association's International Stroke Conference 2023.

13 Feb 2023

SARS-CoV-2 infection and Ad26.COV2.S vaccination may increase risk of stroke post-vaccination

Researchers examined the factors associated with stroke following coronavirus disease 2019 (COVID-19) vaccination.

13 Feb 2023

Statewide analysis of deaths in Florida associated with cannabis use

In the United States, 49.6 million Americans ages 12 and older used cannabis or marijuana in 2020. More than 5.4 million Americans are medical cannabis patients.

10 Feb 2023

Researchers discover how a protein deficiency can prepare the brain to minimize damage after stress

Astrocytes, small star-shaped cells, play an important role in signal transmission in the brain. Since the protein Ezrin is found abundantly in astrocyte tendrils, it is presumed to play a role in brain function.

3 Feb 2023

Lifestyle-related metabolite biomarker may be a target to reduce stroke risk in Black adults

Researchers have identified a lifestyle-related metabolite biomarker called gluconic acid that is associated with high blood pressure, increased risk of ischemic stroke, eating a Southern diet, lower level of education and lack of exercise, among Black adults, according to preliminary research to be presented at the American Stroke Association's International Stroke Conference 2023.

2 Feb 2023

Trial shows the benefit of using a celery seed-derived medication after clot treatment in stroke patients

People who had an ischemic (clot-caused) stroke and were treated with a clot-busting medication and/or mechanical clot removal and also received butylphthalide, a medication initially compounded from celery seed, experienced milder neurological symptoms with better functioning at three months after the stroke, compared to stroke patients who had their clots treated but received a placebo medication, according to preliminary research to be presented at the American Stroke Association's International Stroke Conference 2023.

2 Feb 2023

Health impact of a combination of intermittent fasting and ketogenic diet

Researchers discuss strategies to apply a combination of intermittent fasting and the ketogenic diet to manage chronic health conditions.

31 Jan 2023

Migraine diagnosed prior to pregnancy linked to adverse outcomes during pregnancy

Women are disproportionately affected by migraine, especially during their reproductive years. However, the relationship between migraine and adverse pregnancy outcomes has not been well understood.

31 Jan 2023

The safety profile of the first and second monovalent and bivalent BNT162b2 mRNA booster vaccines in older adults

Researchers evaluated the safety profiles of booster doses of the monovalent and bivalent mRNA COVID-19 vaccine BNT162b2 in adults above the age of 60.

30 Jan 2023

Transient ischemic attack needs emergency assessment to help prevent a full-blown stroke

Stroke symptoms that disappear in under an hour, known as a transient ischemic attack (TIA), need emergency assessment to help prevent a full-blown stroke, according to a new American Heart Association scientific statement published today in the Association's journal Stroke.

19 Jan 2023

Lifestyle and genetic factors influence risk of cardiovascular complications after COVID-19

Researchers examined the contribution of lifestyle and genetic factors to cardiovascular and thromboembolic event (CVE) risk following coronavirus disease 2019 (COVID-19).

11 Jan 2023

RNAs may be a promising biomarker and therapeutic target for ischemic stroke

RUDN doctors analyzed the latest research on the use of RNA for the treatment and diagnosis of ischemic stroke.

10 Jan 2023

After nearly four decades of decline, stroke mortality risk appears to be increasing again in the U.S.

A Rutgers analysis of U.S. stroke deaths from 1975 to 2019 has found both a dramatic decline and the potential for an important resurgence.

6 Jan 2023

New study to examine the effectiveness of stroke treatment for patients with disabilities

When conducting clinical research, investigators aim to control as many variables as possible so it is easier to examine the effectiveness of new treatments.

3 Jan 2023

HU begins human trial for promising treatment to reverse paralysis and language disorder after stroke

Hiroshima University started the human trial for a promising treatment that offers hope in potentially reversing paralysis and language disorder after moderate to severe stroke using therapeutically superior mesenchymal stem cells (MSCs) derived from the cranial bone.

1 Dec 2022

Large COVID vaccination study found that thrombosis and thrombocytopenia are very rare complications

Researchers determine the rates of thrombosis, thrombocytopenia, and thrombosis with thrombocytopenia following COVID-19 vaccination and infection.

28 Nov 2022

Study finds that pediatric stroke is associated with COVID-19 infections but not with multisystem inflammatory syndrome

Researchers investigated whether coronavirus disease 2019 (COVID-19) and multisystem inflammatory syndrome in children (MIS-C) were associated with an increased risk of ischemic stroke in pediatric populations.

24 Nov 2022

Kessler and BrainQ partner on a national trial of breakthrough device to improve recovery after stroke

Researchers from Kessler Foundation and Kessler Institute for Rehabilitation (collectively "Kessler") are enrolling participants in a national trial of a breakthrough device for improving recovery after stroke. Kessler locations in West Orange and Saddle Brook, NJ, are among the 20 sites across the U.S. participating in the EMAGINE Stroke Recovery Trial, which pairs therapeutic exercise with stimulation of the brain through an investigational wearable device.

20 Nov 2022

Severe or morbid obesity in youth linked to higher risk of early atrial fibrillation

Severe or morbid obesity at age 18 may be linked to an elevated risk of atrial fibrillation in younger middle age.

9 Nov 2022

Cedars-Sinai experts to present innovative heart research data during AHA Scientific Sessions 2022

During American Heart Association Scientific Sessions 2022, Prominent Cedars-Sinai Cardiologists, Cardiothoracic Surgeons and Interventionalists Available for Interviews

3 Nov 2022